Arch Venture Fund X Overage, L.p. - Net Worth and Insider Trading
Arch Venture Fund X Overage, L.p. Net Worth
The estimated net worth of Arch Venture Fund X Overage, L.p. is at least $60 Million dollars as of 2024-08-24. Arch Venture Fund X Overage, L.p. is the 10% Owner of Sana Biotechnology Inc and owns about 10,301,250 shares of Sana Biotechnology Inc (SANA) stock worth over $60 Million. Details can be seen in Arch Venture Fund X Overage, L.p.'s Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Arch Venture Fund X Overage, L.p. has not made any transactions after 2024-02-08 and currently still holds the listed stock(s).
Transaction Summary of Arch Venture Fund X Overage, L.p.
Arch Venture Fund X Overage, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Arch Venture Fund X Overage, L.p. owns 6 companies in total, including Sienna Biopharmaceuticals Inc (SNNAQ) , Erasca Inc (ERAS) , and Sana Biotechnology Inc (SANA) among others .
Insider Ownership Summary of Arch Venture Fund X Overage, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SNNAQ | Sienna Biopharmaceuticals Inc | 2019-02-22 | 10 percent owner |
ERAS | Erasca Inc | 2021-07-15 | 10 percent owner |
SANA | Sana Biotechnology Inc | 2024-02-08 | 10 percent owner |
2021-06-16 | 10 percent owner | ||
2022-10-19 | 10 percent owner | ||
2023-09-14 | 10 percent owner |
Arch Venture Fund X Overage, L.p. Latest Holdings Summary
Arch Venture Fund X Overage, L.p. currently owns a total of 1 stock. Arch Venture Fund X Overage, L.p. owns 10,301,250 shares of Sana Biotechnology Inc (SANA) as of February 8, 2024, with a value of $60 Million.
Latest Holdings of Arch Venture Fund X Overage, L.p.
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SANA | Sana Biotechnology Inc | 2024-02-08 | 10,301,250 | 5.84 | 60,159,300 |
Holding Weightings of Arch Venture Fund X Overage, L.p.
Arch Venture Fund X Overage, L.p. Form 4 Trading Tracker
According to the SEC Form 4 filings, Arch Venture Fund X Overage, L.p. has made a total of 1 transactions in Sana Biotechnology Inc (SANA) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Sana Biotechnology Inc is the acquisition of 1,818,181 shares on February 8, 2024, which cost Arch Venture Fund X Overage, L.p. around $10 Million.
Insider Trading History of Arch Venture Fund X Overage, L.p.
- 1
Arch Venture Fund X Overage, L.p. Trading Performance
GuruFocus tracks the stock performance after each of Arch Venture Fund X Overage, L.p.'s buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Arch Venture Fund X Overage, L.p. is 54.06%. GuruFocus also compares Arch Venture Fund X Overage, L.p.'s trading performance to market benchmark return within the same time period. The performance of stocks bought by Arch Venture Fund X Overage, L.p. within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Arch Venture Fund X Overage, L.p.'s insider trading performs compared to the benchmark.
Performance of Arch Venture Fund X Overage, L.p.
Arch Venture Fund X Overage, L.p. Ownership Network
Ownership Network List of Arch Venture Fund X Overage, L.p.
Ownership Network Relation of Arch Venture Fund X Overage, L.p.
Arch Venture Fund X Overage, L.p. Owned Company Details
What does Sienna Biopharmaceuticals Inc do?
Who are the key executives at Sienna Biopharmaceuticals Inc?
Arch Venture Fund X Overage, L.p. is the 10 percent owner of Sienna Biopharmaceuticals Inc. Other key executives at Sienna Biopharmaceuticals Inc include Chief Financial Officer Alexander Azoy , Chief Medical Officer Paul F. Lizzul , and director & President & CEO Iii Frederick Beddingfield .
Sienna Biopharmaceuticals Inc (SNNAQ) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sienna Biopharmaceuticals Inc (SNNAQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Sienna Biopharmaceuticals Inc (SNNAQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Sienna Biopharmaceuticals Inc Insider Transactions
Arch Venture Fund X Overage, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Arch Venture Fund X Overage, L.p.. You might contact Arch Venture Fund X Overage, L.p. via mailing address: 8755 W. Higgins Road, Suite 1025, Chicago Il 60631.